SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001576885-24-000064
Filing Date
2024-05-14
Accepted
2024-05-14 16:47:04
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q abos-20240331.htm   iXBRL 10-Q 802250
2 EX-31.1 abos-20240331x10qxexx311.htm EX-31.1 10612
3 EX-31.2 abos-20240331x10qxexx312.htm EX-31.2 10644
4 EX-32.1 abos-20240331x10qxexx321.htm EX-32.1 5019
5 EX-32.2 abos-20240331x10qxexx322.htm EX-32.2 5062
  Complete submission text file 0001576885-24-000064.txt   5623531

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abos-20240331.xsd EX-101.SCH 44081
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abos-20240331_cal.xml EX-101.CAL 85467
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abos-20240331_def.xml EX-101.DEF 204557
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abos-20240331_lab.xml EX-101.LAB 526743
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abos-20240331_pre.xml EX-101.PRE 372560
77 EXTRACTED XBRL INSTANCE DOCUMENT abos-20240331_htm.xml XML 790315
Mailing Address 427 PARK ST. CHARLOTTESVILLE VA 22902
Business Address 427 PARK ST. CHARLOTTESVILLE VA 22902 925-368-8508
Acumen Pharmaceuticals, Inc. (Filer) CIK: 0001576885 (see all company filings)

IRS No.: 364108129 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40551 | Film No.: 24945273
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)